Prolonged allogeneic islet graft survival by protoporphyrins

Antonello Pileggi, R. Damaris Molano, Thierry Berney, Hirohito Ichii, Sergio San Jose, Elsie Zahr, Raffaella Poggioli, Elina Linetsky, Camillo Ricordi, Luca Inverardi

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

Transplantation of islets of Langerhans in patients with type 1 diabetes allows for improved metabolic control and insulin independence. The need for chronic immunosuppression limits this procedure to selected patients with brittle diabetes. Definition of therapeutic strategies allowing permanent engraftment without the need for chronic immunosuppression could overcome such limitations. We tested the effect of the use of protoporphyrins (CoPP and FePP), powerful inducers of the cytoprotective protein heme-oxygenase I (HO-1), on allogeneic islet graft survival. Chemically induced diabetic C57BL/6 mice received DBA/2 islets. Treatment consisted in peritransplant administration of CoPP or saline. Islets were either cultured in the presence of FePP or vehicle before implant. Short-course administration of CoPP led to long-term islet allograft survival in a sizable proportion of recipients. Long-term graft-bearing animals rejected third-party islets while accepting a second set donor-specific graft permanently, without additional treatment. Preconditioning of islets with FePP by itself led to improved graft survival in untreated recipients, and provided additional advantage in CoPP-treated recipients, resulting in an increased proportion of long-term surviving grafts. Preconditioning of the graft with protoporphyrins prior to implant resulted in reduction of class II expression. Administration of protoporphyrins to the recipients of allogeneic islets also resulted in transient powerful immunosuppression with reduced lymphocyte proliferative responses, increased proportion of regulatory cells (CD4+CD25+), decreased mononuclear cell infiltrating the graft, paralleled by a systemic upregulation of HO-1 expression. All these mechanisms may have contributed to the induction of donor-specific hyporesponsiveness in a proportion of the protoporphyrin- treated animals.

Original languageEnglish (US)
Pages (from-to)85-96
Number of pages12
JournalCell Transplantation
Volume14
Issue number2-3
DOIs
StatePublished - Jan 1 2005

Keywords

  • Allograft survival
  • Cobalt protoporphyrin (CoPP)
  • Diabetes
  • Heme oxygenase-1 (HO-1)
  • Iron protoporphyrin (FePP, hemin)
  • Islet transplantation
  • MHC class II
  • Tolerance

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Fingerprint Dive into the research topics of 'Prolonged allogeneic islet graft survival by protoporphyrins'. Together they form a unique fingerprint.

  • Cite this

    Pileggi, A., Molano, R. D., Berney, T., Ichii, H., San Jose, S., Zahr, E., Poggioli, R., Linetsky, E., Ricordi, C., & Inverardi, L. (2005). Prolonged allogeneic islet graft survival by protoporphyrins. Cell Transplantation, 14(2-3), 85-96. https://doi.org/10.3727/000000005783983160